{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-093936","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.277279+00:00","generated_at":"2026-05-31T10:52:00.944770+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CytomX Q2 2024 cash $137.2M; revenue $25.1M; CX-904 update expected by year-end","bullets":["Cash, equivalents and investments $137.2M at June 30, 2024, down from $150.3M at March 31, 2024.","Total revenue $25.1M in Q2 2024, up from $24.7M in Q2 2023; R&D expense $25.2M incl. $5M milestone to AbbVie.","CX-904 (EGFRxCD3) Phase 1a enrollment continues in PDAC, NSCLC, HNSCC; program update expected by end of 2024.","CX-2051 (EpCAM ADC) Phase 1 dose escalation in third cohort; initial data expected in first half of 2025.","CX-801 (IFNα2b cytokine) first clinical site active; initial data expected in 2025; $10M Astellas milestones achieved YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-093936","json":"https://secwatch.observer/filing/0000950170-24-093936.json","markdown":"https://secwatch.observer/filing/0000950170-24-093936.md","text":"https://secwatch.observer/filing/0000950170-24-093936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000095017024093936/0000950170-24-093936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000095017024093936/ctmx-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:52:00.944770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}